NCR3 and colorectal carcinoma: However, CRC-NK cells presented a profound disequilibrium with underexpression of CD16, NKG2D, DNAM-1, NKp30, NKp46, CD161, and CD158a and overexpression of the inhibitory receptors CD85j and NKG2A.